Evidence map›Paper›PMID 42832079›Full record

ArticleJournal of robotic surgery2026

Targeted pelvic lymph node dissection using magnetic resonance imaging - ultrasonography fusion technique and indocyanine green injection in robot-assisted radical prostatectomy.

Yuta Yamada, Naoki Kimura, Yuji Hakozaki, Masaki Nakamura, Koki Sugano, Kazuma Sugimoto, Shigenori Kakutani, Jimpei Miyakawa, Jun Kamei, Aya Niimi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuta YamadaDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Naoki KimuraDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan. nkimura2026@gmail.com.
Yuji HakozakiDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Masaki NakamuraDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Koki SuganoDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Kazuma SugimotoDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Shigenori KakutaniDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Jimpei MiyakawaDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Jun KameiDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Aya NiimiDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Satoru TaguchiDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Haruki KumeDepartment of Urology, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study assessed the diagnostic accuracy and potential therapeutic value in performing targeted pelvic lymph node dissection (PLND) guided by magnetic resonance imaging (MRI)-ultrasonography (US) fusion combined with Indocyanine green (ICG) injection (tPLND-MUI). This study was retrospectively designed and included 72 patients who underwent robotic radical prostatectomy (RARP) combined with PLND. The inclusion criteria were: (1) prostate cancer with a Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1) category 4 or 5 lesion on MRI, (2) Patients who had clinical records of ICG fluorescence or surgical videos of PLND. The clinical impact of the tPLND-MUI was assessed based on its diagnostic accuracy for identifying nodal metastasis and its potential therapeutic value in achieving complete removal of metastatic lymph nodes. A backup PLND using the super-extended template (sePLND) was performed, and outcomes of tPLND-MUI, limited-PLND (limPLND), extended-PLND (ePLND), and standard-PLND (sPLND) were compared against sePLND. A total of 72 patients were incorporated into the final analysis. tPLND-MUI resulted in a median removal of 29 lymph nodes which were fewer than those of sePLND and ePLND. For detecting at least one lymph node metastasis, sensitivity reached 100% with both ePLND and tPLND-MUI, 95.2% with sPLND, and 71.4% with lim-PLND. The ratios of complete removal of lymph node metastases were 81.0% for ePLND, 66.7% for sPLND, 33.3% for limPLND, and 95.2% for tPLND-MUI. tPLND-MUI may demonstrate excellent therapeutic and diagnostic performance despite the removal of fewer lymph nodes and fewer dissecting regions. Further prospective research is needed to validate these findings.

Indexed as

Indocyanine GreenLymph Node ExcisionMagnetic Resonance ImagingProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedHumansLymphatic MetastasisLymph NodesMaleMiddle AgedPelvisRetrospective StudiesUltrasonographyIndocyanine GreenIndocyanineMRI-US fusionPelvic lymphadenectomyProstate cancerRobot-assisted radical prostatectomy

Identifiers

PMID42832079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.